Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Dipeptidyl peptidase 4 inhibitor

A. (2006) The incretin system glucagonlike peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type... [Pg.418]

Ahran B. Dipeptidyl peptidase-4 inhibitors - clinical data and clinical implications. Diabetes Care 2007 30 1344-50. [Pg.777]

Charbonel B, Karasik A, Ji Liu, Mei Wu, Meininger G, for the Sitagliptin Study 020 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. Diabetes Care 2006 29 2638-43. [Pg.777]

Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE Sitagliptin Study 021 Group. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 2006 29(12) 2632-7. [Pg.384]

Herman GA, Bergman A, Yi B, Kipnes M The Sitagliptin Study 012 Group. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes. Curr Med Res Opin 2006 22(10) 1939 t7. [Pg.384]

Herman GA, Bergman A, Stevens C, Kotey P, Yi B, Zhao P, et al. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab 2006 91 4612--1619. [Pg.138]

Sanford M (2014) Dulaglutide first global approval. Drugs 74 2097-2103 Scheen AJ (2013) Cardiovascular effects of dipeptidyl peptidase-4 inhibitors from risk factors to clinical outcomes. Postgrad Med 125 7-20... [Pg.273]

Wu S, Hopper I, Skiba M, Krum H (2014) Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes meta-analysis of randomized clinical trials with 55,141 participants. Caidiovasc Ther 32 147-158... [Pg.277]

Patil HR, Al Badarin FJ, Al Shami HA, Bhatti SK, Lavie CJ, Bell DSH, O Keefe JH (2012) Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus. Am J Cardiol 110 826-833... [Pg.204]

Kim S-H, Lee S-H, Yim H-J (2013) Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor first new anti-diabetic drug in the history of Korean pharmaceutical industry. Arch Pharm Res 36 1185-1188... [Pg.205]

Scheen A (2013) Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis. Expert Opin Drug Saf 12 545-557... [Pg.206]

Deacon CF, Holst JJ (2013) Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes comparison, efficacy and safety. Expert Opin Pharmacother 14 2047-2058... [Pg.206]

Fukuda-Tsuru S, Anabuki J, Abe Y, Yoshida K, Ishii S (2012) A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglyeemia and dyslipidemia after single and repeated administrations. Eur J Pharmacol 696 194-202... [Pg.208]

Tuhpano G, Sibilia V, Caroli AM, Cocchi D (2011) Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors. Peptides 32 835 838... [Pg.209]

Goossen K, Graber S. Longer term safety of dipeptidyl peptidase-4 inhibitors inpatients with type 2 diabetes mellitus systematic review and meta-analysis. Diabetes Obes Metab 2012 14 1061-107. [Pg.656]

Liu Y, Hu Y, Liu T (2012) Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors medicinal chemistry and preclinical aspects. Curr Med Chem 19 3982-3999... [Pg.669]

Irons BK, Weis JM, Stapleton MR, Edwards KL (2012) An update in incretin-based therapy a focus on dipeptidyl peptidase 4 inhibitors. Curr Diabetes Rev 8 169-182... [Pg.670]

See other pages where Dipeptidyl peptidase 4 inhibitor is mentioned: [Pg.116]    [Pg.655]    [Pg.657]    [Pg.566]    [Pg.132]    [Pg.284]    [Pg.116]    [Pg.541]    [Pg.138]    [Pg.132]    [Pg.272]    [Pg.647]    [Pg.670]   
See also in sourсe #XX -- [ Pg.40 , Pg.149 ]



SEARCH



Dipeptidyl

Dipeptidyl peptidase 4 inhibitors infection

Dipeptidyl peptidase-IV inhibitors

Endogenous Glucoregulatory Peptide Hormones and Dipeptidyl Peptidase IV (DPP4) Inhibitors

Peptidases

Peptidases dipeptidyl-peptidase

Peptidases inhibitors

Treatment dipeptidyl peptidase-4 inhibitors

© 2024 chempedia.info